This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a medication used to treat type 2 diabetes, with a ceiling value of $13,502.22 and a completion date of December 12, 2024.
The contract is a Firm Fixed Price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order for Ozempic is likely one of many such orders placed under the overarching IDC.
Generated 3/12/25, 9:43 AM